The Donor Difference
Counting protocolGMP GMP
GMP Cryopreserved PBMCs
Industry-first ready-to-use GMP PBMC vials
Manufacturing failures and cost overruns stall CGT programs. Characterized GMP PBMCs remove the logistics and target-cell isolation bottleneck, with off-the-shelf lots you can pre-screen before you sign anything.
IsolationClosed · Sepax C-ProCleanroomISO 7FormatsVial · Bag
Why AllCells
Why choose AllCells GMP PBMCs
01
End-to-end donor control
Screening, leukapheresis, processing and cryopreservation under one roof, for traceability and compliance.
02
Faster delivery
Rapid closed-system isolation in an ISO 7 cleanroom with minimal hold time preserves viability and function.
03
Predictive batches
Pre-screen off-the-shelf lots to predict downstream performance.
04
Faster timelines
No SOW or MSA needed for off-the-shelf lots.
Compare
Off-the-shelf vs made-to-order
| Parameter | Off-the-shelf | Made-to-order |
|---|---|---|
| Donor meets 21 CFR 1271 criteria | ✓ | ✓ |
| Program-specific IDM and donor criteria | — | ✓ |
| Closed isolation system (Sepax C-Pro) | ✓ | ✓ |
| Viability and cell concentration specifications | ✓ | ✓ |
| Donor HLA typed | ✓ | ✓ |
| Vial format | ✓ | ✓ |
| Bag format | Inquire | ✓ |
| Lot pre-screening | ✓ | Inquire |
| SOW / MSA required | — | ✓ |
| CoA, Summary of Records, immunophenotype report | ✓ | ✓ |
Vial and bag format specification values are listed in the product brochure.
Learn more
Resources
Protocols, webinars and articles from our scientists. Technical questions go straight to the Customer Success Team.